Squar Milner Financial Services’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-30,682
Closed -$952K 142
2020
Q2
$952K Buy
30,682
+6,985
+29% +$237K 0.54% 45
2020
Q1
$733K Buy
23,697
+2,111
+10% +$71.9K 0.44% 41
2019
Q4
$802K Sell
21,586
-15,130
-41% -$539K 0.4% 44
2019
Q3
$1.28M Buy
36,716
+14,115
+62% +$513K 0.65% 35
2019
Q2
$929K Buy
22,601
+1,116
+5% +$44.3K 0.63% 27
2019
Q1
$865K Buy
21,485
+1,594
+8% +$63.8K 0.64% 28
2018
Q4
$824K Buy
19,891
+260
+1% +$10.8K 0.79% 22
2018
Q3
$821K Sell
19,631
-6,737
-26% -$259K 0.74% 21
2018
Q2
$908K Sell
26,368
-142
-0.5% -$4.85K 0.8% 20
2018
Q1
$893K Buy
26,510
+1,173
+5% +$40.3K 1.13% 18
2017
Q4
$938K Buy
+25,337
New +$864K 1.14% 18

Other funds holding PFE

Squar Milner Financial Services's PFE Position: Q3 2020 in Review

Squar Milner Financial Services sold out of Pfizer (PFE) in Q3 2020, closing a stake of 30,682 shares — an estimated $952K sold.

Squar Milner Financial Services first reported a position in PFE in Q4 2017 and held it in 11 quarters. The position peaked at $1.28M in Q3 2019. 2,508 funds tracked by Wall St. Rank hold PFE as of Q3 2020.

  • Squar Milner Financial Services reported no remaining Pfizer position as of Q3 2020 after selling out during the quarter.
  • Squar Milner Financial Services sold 30,682 Pfizer shares in Q3 2020, an estimated $952K.
  • Squar Milner Financial Services first reported a position in Pfizer in Q4 2017 and held it in 11 quarters.
  • Squar Milner Financial Services's Pfizer position peaked at $1.28M in Q3 2019.
  • 2,508 funds tracked by Wall St. Rank held Pfizer as of Q3 2020.

Based on Squar Milner Financial Services's 13F filing for Q3 2020.